As Expanded Access programs scale globally and extend over longer durations, the question of charging for treatment continues to surface – often uncomfortably – inside organizations.

This interactive session explores the ethical, regulatory, and operational arguments for and against charging within Expanded Access, examining:

• When charging is raised as a sustainability lever
• Where it risks undermining patient trust or ethical intent
• What different regions, program types, and disease areas shape the conversation

Through structured discussion and audience participation, attendees will unpack how these decisions are really being debated today